Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prenatal paracetamol exposure and child neurodevelopment: A review
Show others and affiliations
2018 (English)In: Hormones and Behavior, ISSN 0018-506X, E-ISSN 1095-6867Article in journal (Refereed) Published
Abstract [en]

Background: The non-prescription medication paracetamol (acetaminophen, APAP) is currently recommended as a safe pain and fever treatment during pregnancy. However, recent studies suggest a possible association between APAP use in pregnancy and offspring neurodevelopment. Objectives: To conduct a review of publications reporting associations between prenatal APAP use and offspring neurodevelopmental outcomes. Methods: Relevant sources were identified through a key word search of multiple databases (Medline, CINAHL, OVID and TOXNET) in September 2016. All English language observational studies of pregnancy APAP and three classes of neurodevelopmental outcomes (autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and intelligence quotient (IQ)) were included. One reviewer (AZB) independently screened all titles and abstracts, extracted and analyzed the data. Results: 64 studies were retrieved and 55 were ineligible. Nine prospective cohort studies fulfilled all inclusion criteria. Data pooling was not appropriate due to heterogeneity in outcomes. All included studies suggested an association between prenatal APAP exposure and the neurodevelopmental outcomes; ADHD, ASD, or lower IQ. Longer duration of APAP use was associated with increased risk. Associations were strongest for hyperactivity and attention-related outcomes. Little modification of associations by indication for use was reported. Conclusions: Together, these nine studies suggest an increased risk of adverse neurodevelopmental outcomes following prenatal APAP exposure. Further studies are urgently needed with; precise indication of use and exposure assessment of use both in utero and in early life. Given the current findings, pregnant women should be cautioned against indiscriminate use of APAP. These results have substantial public health implications.

Place, publisher, year, edition, pages
Academic Press Inc. , 2018.
Keyword [en]
Acetaminophen, ADHD, APAP, ASD, Attention deficit hyperactivity disorder, Autism, Autism spectrum disorder, Behavior, Hyperactivity, Neurodevelopment, Paracetamol
Identifiers
URN: urn:nbn:se:kau:diva-66535DOI: 10.1016/j.yhbeh.2018.01.003Scopus ID: 2-s2.0-85041583914OAI: oai:DiVA.org:kau-66535DiVA, id: diva2:1187041
Note

Export Date: 2 March 2018; Article in Press; CODEN: HOBEA; Correspondence Address: Bauer, A.Z.email: Ann_Bauer@uml.edu

Available from: 2018-03-02 Created: 2018-03-02 Last updated: 2018-03-02

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus
In the same journal
Hormones and Behavior

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf